Most enterprises are hindered by "legacy debt" and siloed data, leaving them with massive datasets that function merely as expensive storage rather than a...
Despite having a longer life expectancy compared to men, women in the U.S. generally have a higher prevalence of chronic conditions. Complicating matters, women’s...
The 2025 HIPAA Security Rule updates take effect in 2026 and introduce stricter technical safeguard requirements for any entity that handles electronic protected health...
How can lean life sciences teams generate credible real-world evidence without slowing down? This case study shows how a mid-size organization used HealthVerity eXOs...
As AI tools and data-driven strategies reshape the competitive landscape, organizations are racing to turn AI-powered aspirations into measurable results. But speed without a...
Can you trust AI to generate real-world evidence? This validation study puts HealthVerity eXOs to the test using the ISPOR ELEVATE-GenAI framework, demonstrating high...
Emerging pharma teams face growing pressure to answer critical real-world evidence questions—without the resources of large organizations. The RWE Backlog Problem explores how limited...
Pharmaceutical and biopharmaceutical companies are navigating tightening regulations, rising R&D costs, and intensifying competition, prompting a comprehensive reassessment of their production systems. By leveraging...
PFAS are long-lasting chemical compounds used in many industrial and consumer applications, now widely detected in the environment and linked to potential health concerns....